Reuters -- Shire and Johnson & Johnson won the backing of Europe's highest court on Thursday in their battle for data exclusivity against a generic rival for Alzheimer's drug Reminyl, the court said.
Reuters -- Shire and Johnson & Johnson won the backing of Europe's highest court on Thursday in their battle for data exclusivity against a generic rival for Alzheimer's drug Reminyl, the court said.
